• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明质酸灌注治疗对 BPS/IC 合并单纯复发性尿路感染患者症状缓解的疗效-一项多中心研究的长期结果。

Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study.

机构信息

Department of Medical and Surgical Specialities, "Transilvania" University of Brasov, Brasov, Romania.

Department of Pharmacy, University of Oradea, Oradea, Romania.

出版信息

Eur J Pharm Sci. 2019 Nov 1;139:105067. doi: 10.1016/j.ejps.2019.105067. Epub 2019 Sep 6.

DOI:10.1016/j.ejps.2019.105067
PMID:31499170
Abstract

The purpose of this study is to evaluate the efficacy of intra-vesical instillations with hyaluronic acid (HA) in relieving lower urinary tract irritation symptoms in patients with urinary tract infections (UTIs) and bladder pain syndrome/interstitial cystitis (BPS/IC). This research, conducted in Romania, includes 30 patients with UTIs (Group I) and 24 with BPS/IC (Group II) as defined by European Association of Urology (EAU) Diagnostic Criteria. Data were collected prospectively, using pre- and post-treatment questionnaires for pelvic pain with a symptom scale for urination and frequency as well as visual analog scale (VAS) pain quizzes. At follow-up visits, at an average of 20 months, a significant improvement in urinary bladder pain, day-time urinary frequency and quality of life was observed in Group I patients. Group II patients experienced significant improvement in urinary bladder pain, urgency, nocturia and quality of life at the 15-month follow-up visit. Eighteen patients (75%) showed a complete response to intravesical HA instillations and required no further treatment. Our study demonstrates that intravesical HA instillations may be considered as an important treatment component, with long term positive effects in therapeutic strategy for optimal results in uncomplicated recurrent UTIs and BPS/IC, with good compliance and minimal side effects.

摘要

本研究旨在评估膀胱内注射透明质酸(HA)在缓解尿路感染(UTI)和膀胱疼痛综合征/间质性膀胱炎(BPS/IC)患者下尿路刺激症状方面的疗效。这项在罗马尼亚进行的研究纳入了 30 名符合欧洲泌尿外科学会(EAU)诊断标准的 UTI 患者(I 组)和 24 名 BPS/IC 患者(II 组)。前瞻性收集数据,使用治疗前后盆腔疼痛问卷,包括排尿和频率症状量表以及视觉模拟量表(VAS)疼痛问卷。在平均 20 个月的随访中,I 组患者的膀胱疼痛、白天尿频和生活质量显著改善。在 15 个月的随访中,II 组患者的膀胱疼痛、尿急、夜尿和生活质量也显著改善。18 名患者(75%)对膀胱内 HA 灌注有完全反应,无需进一步治疗。我们的研究表明,膀胱内 HA 灌注可作为一种重要的治疗手段,在治疗单纯复发性 UTI 和 BPS/IC 方面具有长期的积极效果,患者依从性好,副作用小。

相似文献

1
Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study.透明质酸灌注治疗对 BPS/IC 合并单纯复发性尿路感染患者症状缓解的疗效-一项多中心研究的长期结果。
Eur J Pharm Sci. 2019 Nov 1;139:105067. doi: 10.1016/j.ejps.2019.105067. Epub 2019 Sep 6.
2
The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.膀胱内透明质酸治疗对间质性膀胱炎/膀胱疼痛综合征女性患者尿动力学和临床结局的影响。
Taiwan J Obstet Gynecol. 2020 Nov;59(6):922-926. doi: 10.1016/j.tjog.2020.09.021.
3
Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.透明质酸治疗后间质性膀胱炎/膀胱疼痛综合征女性的泌尿及心理结局
Taiwan J Obstet Gynecol. 2018 Jun;57(3):360-363. doi: 10.1016/j.tjog.2018.04.006.
4
Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.透明质酸改善了间质性膀胱炎女性的疼痛症状,甚于改善其膀胱储尿症状。
Taiwan J Obstet Gynecol. 2019 May;58(3):417-422. doi: 10.1016/j.tjog.2018.11.033.
5
Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.膀胱内注射透明质酸溶液治疗难治性间质性膀胱炎/膀胱疼痛综合征后女性性功能的变化。
J Sex Med. 2014 Sep;11(9):2256-63. doi: 10.1111/jsm.12507. Epub 2014 Mar 17.
6
A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.一项关于膀胱疼痛综合征/间质性膀胱炎女性患者膀胱内注射透明质酸和硫酸软骨素与二甲亚砜疗效及安全性的随机、开放标签、多中心研究。
Neurourol Urodyn. 2017 Apr;36(4):1178-1186. doi: 10.1002/nau.23091. Epub 2016 Sep 21.
7
Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.腔内透明质酸与硫酸软骨素治疗膀胱疼痛综合征/间质性膀胱炎的临床比较。
Neurourol Urodyn. 2018 Jan;37(1):257-262. doi: 10.1002/nau.23284. Epub 2017 May 8.
8
Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.透明质酸治疗间质性膀胱炎/膀胱疼痛综合征患者后,尿神经生长因子水平降低,但脑源性神经营养因子水平未降低。
PLoS One. 2014 Mar 10;9(3):e91609. doi: 10.1371/journal.pone.0091609. eCollection 2014.
9
Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?膀胱测压结果能否预测间质性膀胱炎女性膀胱内注射透明质酸的效果?
Eur Urol. 2005 Mar;47(3):393-7; discussion 397. doi: 10.1016/j.eururo.2004.10.022. Epub 2004 Dec 18.
10
Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).接受透明质酸钠-硫酸软骨素联合制剂(Ialuril®)膀胱灌注的患者膀胱黏膜的形态学变化
Urol Int. 2013;91(1):81-8. doi: 10.1159/000345047. Epub 2013 Mar 13.

引用本文的文献

1
Intravesical Instillation of Hyaluronic Acid With Epidermal Growth Factor for Restoring Urothelial Denudation and Alleviating Oxidative Stress in Lipopolysaccharide-Induced Interstitial Cystitis of Rats.膀胱内灌注透明质酸联合表皮生长因子对恢复大鼠脂多糖诱导的间质性膀胱炎中尿路上皮剥脱及减轻氧化应激的作用
Int Neurourol J. 2024 Jun;28(2):106-114. doi: 10.5213/inj.2448028.014. Epub 2024 Jun 30.
2
The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans.用于评估人类间质性再生新分子策略的间质性膀胱炎模型。
Int J Mol Sci. 2024 Feb 15;25(4):2326. doi: 10.3390/ijms25042326.
3
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and -acetylcysteine in Urinary Tract Infections (Uroial PLUS).
尿路健康的新型关键成分——D-甘露糖、硫酸软骨素、透明质酸和 N-乙酰半胱氨酸在尿路感染(Uroial PLUS)中的作用。
Nutrients. 2023 Aug 14;15(16):3573. doi: 10.3390/nu15163573.
4
Elucidations on the Performance and Reversibility of Treatment with Hyaluronic Acid Based Dermal Fillers: In vivo and in vitro Approaches.基于透明质酸的真皮填充剂治疗的性能与可逆性阐释:体内和体外研究方法
Clin Cosmet Investig Dermatol. 2022 Dec 8;15:2629-2640. doi: 10.2147/CCID.S383354. eCollection 2022.
5
Guideline Adherence of Asymptomatic Bacteriuria Could Be Improved among General Practitioners in The Netherlands: A Survey Study.荷兰全科医生对无症状菌尿症指南的遵循情况有望得到改善:一项调查研究
Antibiotics (Basel). 2022 Jan 9;11(1):75. doi: 10.3390/antibiotics11010075.
6
Overactive bladder: A review and update.膀胱过度活动症:综述与更新
Exp Ther Med. 2021 Dec;22(6):1444. doi: 10.3892/etm.2021.10879. Epub 2021 Oct 14.
7
Multicentre International Study for the Prevention with iAluRil of Radio-induced Cystitis (MISTIC): A Randomised Controlled Study.iAluRil预防放射性膀胱炎多中心国际研究(MISTIC):一项随机对照研究
Eur Urol Open Sci. 2021 Feb 23;26:45-54. doi: 10.1016/j.euros.2021.01.016. eCollection 2021 Apr.
8
Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis.药物治疗间质性膀胱炎和膀胱疼痛综合征的疗效和安全性比较:系统评价和贝叶斯网络荟萃分析。
Int Urogynecol J. 2021 May;32(5):1129-1141. doi: 10.1007/s00192-020-04659-w. Epub 2021 Feb 27.